...
首页> 外文期刊>Indian drugs >DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CILNIDIPINE, CHLORTHALIDONE AND TELMISARTAN IN BULK AND TABLET DOSAGE FORM
【24h】

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CILNIDIPINE, CHLORTHALIDONE AND TELMISARTAN IN BULK AND TABLET DOSAGE FORM

机译:DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CILNIDIPINE, CHLORTHALIDONE AND TELMISARTAN IN BULK AND TABLET DOSAGE FORM

获取原文
获取原文并翻译 | 示例
           

摘要

A simple, accurate and precise method was developed for the simultaneous estimation of cilnidipine, chlorthalidone and telmisartan in tablet dosage form on Agilent C18 column (150mmx4.6mm dia., 5p particle size), using buffer and acetonitrile in the ratio of 55:45 V/V, which was pumped through the column with a flow rate of 1ml_/min.The buffer used in this method was 0.1 orthophosphoric acid at a pH of 2.5.The run time was 5 min. and the retention time of cilnidipine, chlorthalidone and telmisartan were found to be2.105min, 2.813min and 3.505min. Reference standard solutions of the drugs were prepared by dissolving firstly in methanol and then diluting with methanol and water (50:50 V/V). This method provides good linearity (R2=0.999) over a range of 5-30pg/mL of cilnidipine,6.25-37.5pg/mL of chlorthalidone and 20-120pg/mL of telmisartan. Optimized wavelength was 238nm. The method was validated in terms of specificity, linearity, accuracy, precision, detection limit, quantification limit, robustness and forced degradation.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号